Stockley's drug interactions : a source book of interactions, their mechanisms, clinical importance and management
Author(s)
Bibliographic Information
Stockley's drug interactions : a source book of interactions, their mechanisms, clinical importance and management
Pharmaceutical Press, 2010
9th ed. / edited by Karen Baxter
- : book
- : CD-ROM
- : CD-ROM + book
Available at 4 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Accompanied by 1 computer laser optical disc "Stockley's drug interactions 9" (4 3/4 in.)
Includes index
Description and Table of Contents
Description
Stockley's Drug Interactions, edited by Karen Baxter, remains the world's most comprehensive and authoritative reference book on drug interactions. * Contains detailed yet concise monographs * Covers interactions between therapeutic drugs, proprietary medicines, herbal medicines, foods, drinks, pesticides and drugs of abuse * Based on published sources and fully referenced * Provides comprehensive details of the clinical evidence for the interactions under discussion, an assessment of their clinical importance and gives clear guidance on how to manage the interaction in practice * Contains over 3,400 monographs New for the 9th edition: * Over 300 new monographs * All monographs fully revised and revalidated * Three new chapters on the interactions of Thyroid Hormones, Urological drugs, and Nutritional agents, Supplements and Vitamins * New drugs launched in the last two years added - including drugs such as fesoterodine, several monoclonal antibodies, new antidiabetics (e.g. sitagliptin) new antineoplastics (e.g. dasatinib) and new immunosuppressants (e.g. temsirolimus) * Updated information on seasonal flu vaccines and antivirals, including all available information on possible interactions with concurrent medication * Increased commentary on the involvement of newer mechanisms in drug interactions, such as drug transporter proteins, and other genetic factors that affect the ability of individuals to metabolise medicines
by "Nielsen BookData"